Rovin Capital UT ADV decreased its stake in shares of Campbell Soup (NASDAQ:CPB – Free Report) by 30.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 10,791 shares of the company’s stock after selling 4,677 shares during the quarter. Rovin Capital UT ADV’s holdings in Campbell Soup were worth $452,000 as of its most recent SEC filing.
Other hedge funds also recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Campbell Soup during the 2nd quarter worth about $32,000. nVerses Capital LLC purchased a new stake in Campbell Soup during the third quarter worth approximately $34,000. Ashton Thomas Securities LLC purchased a new stake in shares of Campbell Soup during the 3rd quarter worth approximately $39,000. Friedenthal Financial acquired a new position in shares of Campbell Soup in the 3rd quarter valued at $48,000. Finally, EverSource Wealth Advisors LLC grew its position in shares of Campbell Soup by 463.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,747 shares of the company’s stock valued at $82,000 after buying an additional 1,437 shares during the last quarter. Institutional investors and hedge funds own 52.35% of the company’s stock.
Campbell Soup Stock Performance
Shares of CPB opened at $38.69 on Thursday. The stock has a market capitalization of $11.53 billion, a P/E ratio of 21.14, a P/E/G ratio of 2.60 and a beta of 0.19. The company has a debt-to-equity ratio of 1.74, a quick ratio of 0.50 and a current ratio of 0.91. Campbell Soup has a 1 year low of $37.61 and a 1 year high of $52.81. The company’s fifty day moving average is $42.78 and its two-hundred day moving average is $46.35.
Campbell Soup Increases Dividend
Insider Buying and Selling
In related news, EVP Anthony Sanzio sold 2,000 shares of the company’s stock in a transaction on Friday, January 3rd. The stock was sold at an average price of $41.90, for a total transaction of $83,800.00. Following the transaction, the executive vice president now owns 16,551 shares of the company’s stock, valued at $693,486.90. This represents a 10.78 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. 20.19% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several research firms have issued reports on CPB. Citigroup decreased their price objective on shares of Campbell Soup from $44.00 to $41.00 and set a “sell” rating for the company in a research note on Thursday, December 5th. DA Davidson reissued a “neutral” rating and issued a $51.00 target price on shares of Campbell Soup in a research report on Wednesday, December 4th. Stephens reaffirmed an “overweight” rating on shares of Campbell Soup in a research report on Wednesday, December 4th. Wells Fargo & Company decreased their price objective on Campbell Soup from $45.00 to $43.00 and set an “equal weight” rating for the company in a report on Tuesday, January 7th. Finally, Argus raised shares of Campbell Soup from a “hold” rating to a “buy” rating and set a $59.00 target price on the stock in a report on Friday, September 20th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $50.75.
Check Out Our Latest Stock Report on Campbell Soup
About Campbell Soup
Campbell Soup Company, together with its subsidiaries, manufactures and markets food and beverage products in the United States and internationally. The company operates through Meals & Beverages and Snacks segments. The Meals & Beverages segment engages in the retail and foodservice businesses in the United States and Canada.
Recommended Stories
- Five stocks we like better than Campbell Soup
- Stock Analyst Ratings and Canadian Analyst Ratings
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- NYSE Stocks Give Investors a Variety of Quality OptionsĀ
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- What is a Death Cross in Stocks?
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Want to see what other hedge funds are holding CPB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Campbell Soup (NASDAQ:CPB – Free Report).
Receive News & Ratings for Campbell Soup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Campbell Soup and related companies with MarketBeat.com's FREE daily email newsletter.